FDA Inspection 1255728 — SGS Analytics Switzerland AG
The FDA completed an inspection of SGS Analytics Switzerland AG on Nov 8, 2024 in Birsfelden. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 8, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Birsfelden (Switzerland)
Additional details
Bioanalytical BA/BE